Pharma-Bio Serv, Inc. PBSV
OTC PK
| 07/31/2026 | 04/30/2026 | 01/31/2026 | 10/31/2025 | 07/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -106.09% | 608.21% | 33,000.00% | 99.95% | -314.15% |
| Total Depreciation and Amortization | 0.74% | -69.23% | -25.34% | 1.54% | -4.11% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -583.70% | 111.26% | -153.54% | 303.74% | -259.70% |
| Change in Net Operating Assets | 117.05% | -61.12% | -666.91% | -85.13% | 190.63% |
| Cash from Operations | 116.67% | 6.36% | -239.47% | 18.27% | 178.42% |
| Capital Expenditure | 39.13% | 4.17% | -500.00% | 80.00% | 53.49% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 82.76% | -168.24% | 422.57% | -152.51% | 150.61% |
| Cash from Investing | 82.71% | -168.21% | 422.95% | -152.60% | 150.48% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | 58.82% | 81.52% | -84.00% | 70.93% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -100,976.47% | 81.52% | -84.00% | 99.71% |
| Foreign Exchange rate Adjustments | -450.00% | -114.74% | 23.38% | 75.00% | -91.46% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 93.12% | -266.59% | 512.17% | -131.02% | 135.76% |